Clovis Oncology flagged the possibility of bankruptcy in the ‘very near term.’ The cancer drugmaker also cited the U.S. and European health regulators’ increased focus on data showing drugs help extend the survival in ovarian cancer patients, which has led to the withdrawal of some cancer drugs. (Reuters)

The Food and Drug Administration’s Pulmonary-Allergy Drugs Advisory Committee backed AstraZeneca’s 2-in-1 asthma inhaler for people aged 18 years and older. In adolescents aged 12 to 17 years, the Committee voted 9 to 8, and for children aged 4 to 11 years, the Committee voted 16 to 1 that the data do not support a favorable benefit-risk assessment for PT027 for asthma. (Benzinga)

Two teaspoons of lab-made blood could have enormous potential for people with rare blood conditions. The experimental transfusion was done at Addenbrooke’s Hospital in Cambridge, England, as part of a collaborative effort among U.K. scientists to understand how lab-made blood transfusions could work. (CNN)

Ionis Pharmaceuticals released its latest earnings, highlighted by a revenue beat in Q3. Ionis announced earnings per share of $-0.33 on revenue of $160 million, while analysts polled had anticipated EPS of $-0.72 on revenue of $145.75 million. (Investing.com)

Ultra-processed, ready-to-eat foods like hot dogs, frozen pizzas, and doughnuts may lead to premature death, researchers found in a recently-published study. Ultra processed foods have long been associated with an increased risk of diseases like diabetes, cardiovascular disease, and cancer. (USA Today)